Home 2017 - Volume 17 (1) GLOBAL ECONOMIC BURDEN OF ASBESTOS RELATED DISEASES IN COMPARISON WITH THE COSTS OF PRODUCTION AND CONSUMPTION
GLOBAL ECONOMIC BURDEN OF ASBESTOS RELATED DISEASES IN COMPARISON WITH THE COSTS OF PRODUCTION AND CONSUMPTION PDF Print E-mail
Wednesday, 10 May 2017 11:26

Syed Mohamed Aljunid 1, 2, Ahmad Munir Qureshi3 and David Baguma4,5

1Department of Health Policy and Management, Faculty of Public Health, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait.

2International Casemix and Clinical Coding Centre (ITCC-UKMMC), University Kebangsaan Malaysia, UKM Medical Centre, Bandar Tun Razak, 56000 Kuala Lumpur, MALAYSIA.

3Monash University (Malaysia), Jeffrey Cheah School of Medicine and Health Sciences, Clinical School, No 8- Jalan Masjid Abu Bakar, 80100 Johor Bahru, Johor, MALAYSIA.

4African Rural University, Uganda.

5 Department of Environmental and Occupational Health, Faculty of Medicine and Health Sciences, Serdang, Malaysia.

Corresponding Author:

Syed Aljunid.

E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

ABSTRACT

Occupational cancers, including mesothelioma and lung cancer are linked to the use of asbestos.  Annually, at least 100,000 global deaths are attributed to asbestos exposure putting a heavy burden on national budgets.  Expenses incurred on treatment of asbestos related diseases (ARDs) reduce households and national resource savings, while ARDs culminate in terminal burdens. The objective of this study is to measure the economic burden of ARDs and to assess the economic impact of asbestos consumption. The health and economic burden of asbestos was estimated in macro-global consumption-production model using production function frontier-based and generalized least squared approach for asbestos products and cost tabulation. Production, in metric tons (Mt) was adopted as a dependent variable among explanatory variables, including consumption. Information on treatment cost of asbestos related diseases (mesothelioma, asbestosis and lung cancer) was obtained from costing information and published literatures. Annual total economic burden of asbestos is at USD 11.92 billion. Out of this cost, USD 4.34 billion per annum is the economic burden of managing three common ARDs. The cost of compensation for patients suffering ARDs is USD 4.28 billion. From the remaining USD 3.3 billion, USD 2.93 billion is the value of asbestos consumed in 2003 and USD372.15 million is the loss of earning due to hospital visits and admissions. For every USD 1 spent on consumption of asbestos, global economy has to absorb almost USD 4 due to health consequences of ARDs. Banning of asbestos production and usage in production of goods has far-reaching impacts on household welfare, health and economic development. The insights revealed are expected to inform decision makers the need to ban all forms of asbestos, especially in developing countries where usage is increasing.

Keywords: Cost, Development, Mesothelioma, Lung cancer, Savings, Welfare, Developing countries.

Full text (PDF)

Last Updated on Wednesday, 10 May 2017 11:28